Fibrispa Tablet

Learn more about Fibrispa Tablet, a quality offering from Fibrica Healthcare Pvt Ltd featuring the therapeutic benefits of Mebeverine (135mg). This formulation is primarily utilized for Irritable bowel syndrome. Browse through the detailed information provided below to enhance your knowledge about this medicine and its potential benefits for you.

MRP: ₹ 125.5
Packing: 10.0 tablets in 1 strip
Salt Combination: Mebeverine (135mg)
Brand: Fibrica Healthcare Pvt Ltd
Uses: Irritable bowel syndrome

Description

Fibrispa Tablet is a prescription medicine used to treat and relieve symptoms of irritable bowel syndrome such as stomach pain and spasm, cramps in the abdomen, gas, bloating, and changes in bowel habits
This medicine relaxes muscles of the intestine and relieves spasms
Fibrispa Tablet should be taken in a dose and duration as advised by your doctor
It is swallowed whole with a drink of water preferably 20 minutes before a meal to relieve or reduce post-meal symptoms
Let your doctor know about all other medications you are taking as some may affect, or be affected by this medicine
You should keep taking this medicine for as long as your doctor recommends
If you stop treatment too early your symptoms may come back and your condition may worsen
Remember following lifestyle modifications like having a fiber-rich diet, increase fluid intake and regular exercise can help you to get better results.
This medicine has very less or minimal side effects but it may cause skin rash, fainting, or angioedema sometimes
Be cautious as it is important to stop the medication and inform the doctor if you encounter difficulty in breathing or swelling of the face, neck, tongue, or throat.
Before taking this medicine, you should let your doctor know if you have liver and kidney problems
Pregnant or breastfeeding women should also consult their doctor before taking this medicine.

Cautions

Liver:	SAFE IF PRESCRIBED: Fibrispa Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Fibrispa Tablet may not be needed in these patients. Please consult your doctor. Caution is advised in patients with severe liver disease.
Kidney:	SAFE IF PRESCRIBED: Fibrispa Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Fibrispa Tablet may not be needed in these patients. Please consult your doctor.^Caution is advised in patients with severe kidney disease.
Driving:	SAFE: Fibrispa Tablet does not usually affect your ability to drive.
Breast feeding:	CONSULT YOUR DOCTOR: Information regarding the use of Fibrispa Tablet during breastfeeding is not available. Please consult your doctor.
Pregnency:	CONSULT YOUR DOCTOR: Fibrispa Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Alcohol:	SAFE: Consuming alcohol with Fibrispa Tablet does not cause any harmful side effects.
Drug Action:	Antispasmodics (IBD)
Therapeutic class:	GASTRO INTESTINAL
Habit Forming:	No
Chemical Class:	P-Methoxybenzoic Acids and Derivatives

Uses of Fibrispa Tablet

Irritable bowel syndrome

Missed Doses

If you miss a dose of Fibrispa Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

FAQs